This Week in Psychedelics - 9.24.21

ThisWeekinPsychedelics.png

Cannabis

  • Switzerland’s Zurich to Begin Recreational Cannabis Trial in 2022 (High Times)

  • U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote (High Times)

  • Green Party in Finland Calls for End of Prohibition (High Times)

  • This company is smuggling tons of legal cannabis into streets, whistleblower alleges (Leafly)

  • California State Fair Will Host Marijuana Competition For The First Time At 2022 Event, Officials Announce (Marijuana Moment)

  • Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week (NORML)

  • Rhode Island Lawmakers Are ‘Very Close’ On Marijuana Legalization Deal Ahead Of Possible Special Session, Top Senator Says (Marijuana Moment)

  • Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble (Lucid News)

  • Pennsylvania Senators Discuss Bill To Provide DUI Protections For Medical Marijuana Patients (Marijuana Moment)

  • VA sending mixed messages for vets about cannabis use to treat PTSD (Arizona Mirror)

  • Delaware: Governor Signs Measure Amending Cannabis Penalties for Minors (NORML)

  • FBI Clarifies That Using Marijuana More Than 24 Times Disqualifies Would-Be Agents (Marijuana Moment)

  • Former Massachusetts Mayor Sentenced for Extortion (High Times)

  • Controlling cannabis and the classification of Delta-8 THC (Reuters)

  • Eaze launches California program to bring free medical cannabis to low-income patients (Greenway Magazine)

  • Mississippi Lawmakers Reach Deal On Medical Marijuana Legalization, Plan To Request Special Session (Marijuana Moment)

  • For Chronic Pain Sufferers, Cannabis "May Be a Source of Hope" (Green Entrepreneur)

  • Full-Page Washington Post Ad Calls For Marijuana Prisoner’s Freedom While Celebs Make Money In Industry (Marijuana Moment)

  • Can Cannabis Help Your Gut? (TIME)

  • Florida Marijuana Activists File New Legalization Initiative For 2022 Ballot Following Supreme Court Defeats (Marijuana Moment)

  • Oklahoma Activists Finalize Language For Two 2022 Marijuana Ballot Initiatives (Marijuana Moment)

  • Nebraska Cannabis Association launches as state's first lobbying group for marijuana-based businesses (York News-Times)

Magic Mushrooms

  • Psilocybin Study for Tobacco Gets Federal Funding (Truffle Report)

  • Thousands attend first-ever psychedelic shroom festival in Ann Arbor (MLive.com)

  • Canadian Coalition Submits Draft for Legal Psilocybin Therapy (Truffle Report)

  • Happy Global Magic Mushroom Day (9/20) for Psilocybin Fans (CelebStoner)

  • Nine Perfect Strangers's Portrayal of Psilocybin Could Derail Progress in Researching Psychedelic Use for Mental Health (Teen Vogue)

  • Shroom Delivery is Now a Thing (DoubleBlind)

  • Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac (Newsweek)

  • Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism (Marijuana Moment)

  • Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 (Psilocybin Alpha)

  • Amanita muscaria – A Fresh Look at An Iconic Mushroom (Psychedelic Science Review)

  • The 25 Best U.S. Counties for Mushroom Foragers (moveBuddha)

  • MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration (Psilocybin Alpha)

  • Eversio Wellness Harvests Its First Legally Grown Psychoactive Mushrooms (Yahoo! Finance)

MDMA

  • Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London (Psilocybin Alpha)

DMT

  • Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy (Psilocybin Alpha)

5-MeO-DMT

  • I Wanted Ego Death. This Powerful Psychedelic Gave It To Me. (BuzzFeed News)

  • Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT (TheNewswire)

Mescaline

  • Mescaline, Veganism, and Schopenhauer’s Philosophy (Sam Woolfe)

Iboga

  • DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder (Psilocybin Alpha)

Salvia Divinorum

  • Salvia Divinorum and Kratom Combination – What You Must Know About It (IRN Post)

Novel Psychoactive Substances

  • Are Prodrugs the Next Wave of Psychedelic Drug Development? (Psychedelic Science Review)

  • Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018 (Psilocybin Alpha)

  • Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders (Psilocybin Alpha)

  • Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug (Yahoo! Finance)

  • Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data (Psilocybin Alpha)

Synthetic Cannabinoids

Nitrous Oxide

  • TikTok Is Hosting Ads for ‘Whipped Cream’. But It’s Actually Nitrous Oxide (VICE)

Ketamine

  • Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S. (Canadian Lawyer)

  • Turning Everyday Therapist Offices into Ketamine Clinics (Lucid News)

  • Statistical model defines ketamine anesthesia’s effects on the brain (MIT News)

  • Is A Ketamine Infusion Covered By Insurance? (Healing Maps)

Miscellaneous

  • Companies are Getting Rid of Drug Tests Because They Can’t Find Enough Workers (VICE)

  • Class A drug possession ‘effectively decriminalised’ in Scotland (The Times)

  • Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice (Psymposia)

  • Italian Advocates Collect 500,000 Signatures for Decriminalization of Cannabis and Psychoactive Substances (High Times)

  • Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It (VICE)

  • Meet Microdosing TikTok—And Why the Community Matters (Psychedelics Today)

  • More Michigan Cities Look to Decriminalize Psychedelics (Truffle Report)

  • The Michigan Poison and Drug Information Center issues notification about effects and risks of using psychedelic substances (Today@Wayne)

  • Criticism of Awakn Treatment Model as Second Clinic Opens for Treating Addiction (TalkingDrugs)

  • Psychedelic Patents: Nature, IP Law, & Exclusion (Truffle Report)

  • How To Come Down From A High: Navigating the Downslope of a Trip (DoubleBlind)

  • Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery (Forbes)

  • Psychedelic Water founder looks to new legal era for powerful drugs (The Washington Times)

  • Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies (Psilocybin Alpha)

  • Why Bristol Uni is taking a more progressive stance on drugs (The Bristol Cable)

  • Numinus Completes Acquisition of Neurology Centre of Toronto (Psilocybin Alpha)

  • The Removal of the Ecuadorian Drug Possession Table: A Major Government Mistake (TalkingDrugs)

  • ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.